Assembly BiosciencesASMB
13F holders, Q2 2024 (June 30)At the end of Q2 2024, 27 institutions reported holding Assembly Biosciences Inc. (ASMB) in their 13F filings, up 3 from Q1 2024. 5 opened new positions and 2 sold out. The largest holders were Armistice Capital, LLC ($6.4M), Vanguard Group Inc. ($2.8M) and Millennium Management ($1.7M). 3 famous investors held it, including Israel Englander (0.0% of Millennium Management's portfolio), Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio) and Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Assembly Biosciences Inc.
- CUSIP
- 045396207
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 5 | $6.8M |
| Exits | 2 | $2K |
All 13F filers, Q1 2024 → Q2 2024: 530,660 shares bought and 2,687 shares sold, net +527,973 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 27 holders
| Armistice Capital, LLC | 0.17% | New | 468,000 | $6.4M |
| Vanguard Group Inc. | 0.00% | Add +2.1% | 200,458 | $2.8M |
| Millennium Management | 0.00% | Reduce -1.2% | 123,458 | $1.7M |
| BlackRock Inc. | 0.00% | Reduce -0.9% | 77,233 | $1.1M |
| Renaissance Technologies | 0.00% | Add +39.2% | 54,911 | $753K |
| Geode Capital Management, LLC | 0.00% | Add +4.2% | 54,409 | $747K |
| Acuitas Investments, LLC | 0.37% | Add +0.5% | 49,996 | $686K |
| Federated Hermes, Inc. | 0.00% | No change | 25,394 | $348K |
| Susquehanna International Group, LLP | 0.00% | New | 17,400 | $239K |
| Bridgeway Capital Management, LLC | 0.00% | No change | 14,500 | $199K |
| Acadian Asset Management LLC | 0.00% | Add +131.1% | 13,558 | $184K |
| State Street Corp. | 0.00% | Add +5.8% | 12,809 | $176K |
| Citadel Advisors | 0.00% | New | 12,746 | $175K |
| FMR LLC | 0.00% | Add +8.0% | 12,220 | $168K |
| Northern Trust Corp. | 0.00% | Add +9.6% | 11,567 | $159K |
| Marquette Asset Management, LLC | 0.02% | No change | 9,016 | $124K |
| Amundi | 0.00% | No change | 7,934 | $96K |
| Barclays PLC | 0.00% | No change | 2,994 | $41K |
| UBS Group AG | 0.00% | Reduce -8.8% | 2,949 | $40K |
| Morgan Stanley | 0.00% | Add +3.6% | 2,562 | $35K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -9.0% | 780 | $11K |
| Rhumbline Advisers | 0.00% | Reduce -4.5% | 190 | $3K |
| JPMorgan Chase & Co. | 0.00% | Add +857.1% | 67 | $919 |
| EverSource Wealth Advisors, LLC | 0.00% | No change | 55 | $803 |
| Bank of America Corp. | 0.00% | New | 46 | $631 |
| Qube Research & Technologies Ltd | 0.00% | No change | 3 | $41 |
| Frazier Financial Advisors, LLC | 0.00% | New | 1 | $14 |
"% of holder's portfolio" is ASMB's weight in each manager's 13F, not the share of Assembly Biosciences Inc. the manager owns.